PTPRG and nasopharyngeal carcinoma: These findings further validate the role of PTPRG in suppressing tumor invasion and metastasis via inhibition of Akt signaling and downstream VEGF, IL6, and IL8 and, thus, inhibiting tumor invasion and liver metastasis in NPC, as identified in this current study.